^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

JS111

i
Other names: JS111, APL1898, AP-L1898
Associations
Company:
Shanghai Junshi Biosci, Suzhou Junjing Biomed
Drug class:
EGFR inhibitor
Related drugs:
Associations
over3years
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer (clinicaltrials.gov)
P1/2, N=156, Recruiting, Suzhou Junjing BioSciences Co., Ltd.
Clinical • New P1/2 trial
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation
|
JS111